sdbn.org

News, Syndication, Xconomy »

The Innovation Imperative: How Corporations and Nations Can Survive the Tsunami of Global Competition and Thrive
Posted by Mary Canady September 3rd, 2010 .
No Comments

Government leaders in Europe and North America are seeking to formulate enlightened, effective policies to create the necessary ecosystems and help their corporations respond to threats of loss of...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

Orexigen Nabs $1B Deal With Takeda to Market Obesity Drug, Shares Climb
Posted by Mary Canady September 2nd, 2010 .
No Comments

San Diego-based Orexigen Therapeutics has found a partner to help it compete in the growing market for drugs to combat obesity. It’s Japan-based Takeda Pharmaceutical. Under the terms of the...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

Otonomy Gets $38.5M, Avalon Helps Restart Drug for Age-Related Blindness, Accumetrics Heads Toward Profitability, & More San Diego Life Sciences News
Posted by Mary Canady September 2nd, 2010 .
No Comments

The life sciences news over the past week was almost all about deals. Money came out of INC Research, a contract research organization in North Carolina that was founded in San Diego. Money went into...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

Accumetrics Adds $7 Million in Venture Funding, Plans to Reach Profitability
Posted by Mary Canady September 1st, 2010 .
No Comments

San Diego-based Accumetrics says today it has raised an additional $7 million as part of a Series E venture round that was announced last October, when the biomedical diagnostics company raised about...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

Cebix Raises $16M From Investors
Posted by Mary Canady September 1st, 2010 .
No Comments

San Diego-based Cebix, which is developing a replacement therapy based on human proinsulin C-peptide as a suppemental treatment for complications from type 1 diabetes, has raised $16 million over the...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

Innovators in Boston, San Diego, San Francisco, Seattle Top World Economic Forum’s List of Technology Pioneers
Posted by Mary Canady September 1st, 2010 .
No Comments

The World Economic Forum—the body behind the exclusive annual gathering in Davos, Switzerland—today released its “Technology Pioneers” list for 2011. An unusually large number...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

Will the Stem Cell Ruling Affect Venture Capital Investing?
Posted by Mary Canady September 1st, 2010 .
No Comments

Last week’s federal district court ruling ordering an immediate halt in federal funding for stem cell research has thrown academic research circles into a state of confusion. This has caught...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

San Diego’s ReVision Therapeutics, Founded in April, Takes on Development of Drug Candidate for Age-Related Blindness
Posted by Mary Canady August 31st, 2010 .
No Comments

A San Diego biopharmaceutical startup, formed just five months ago to resume development of a compound for treating age-related macular degeneration, has reported encouraging results from a two-year,...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

Otonomy Closes $38.5M Round to Fund Trials of Hearing-Disorder Treatments
Posted by Mary Canady August 30th, 2010 .
No Comments

Follow-on funding for Otonomy that Luke presaged in June has been disclosed by the San Diego biotech, a two-year-old startup developing drug treatments for hearing loss and balance disorders. Otonomy...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

First Two Startups Leaving CommNexus Incubator, Qualcomm at 25, Oceanhouse Media Shows App-titude for Children’s Books, & More San Diego BizTech News
Posted by Mary Canady August 30th, 2010 .
No Comments

Of all the tech news we had last week, I thought the most interesting was what our Xconomists had to say about Qualcomm, past and future. We’ve got the wrap on that, along with the rest of what...

[[Click headline to continue reading.]] More...